Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Loss of the repressor REST in uterine fibroids promotes aberrant G protein-coupled receptor 10 expression and activates mammalian target of rapamycin pathway.

Varghese BV, Koohestani F, McWilliams M, Colvin A, Gunewardena S, Kinsey WH, Nowak RA, Nothnick WB, Chennathukuzhi VM.

Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2187-92. doi: 10.1073/pnas.1215759110. Epub 2013 Jan 2.

2.

Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.

Commandeur AE, Styer AK, Teixeira JM.

Hum Reprod Update. 2015 Sep-Oct;21(5):593-615. doi: 10.1093/humupd/dmv030. Epub 2015 Jul 3. Review.

3.

The Epidemiology and Genetics of Uterine Leiomyoma.

Styer AK, Rueda BR.

Best Pract Res Clin Obstet Gynaecol. 2016 Jul;34:3-12. doi: 10.1016/j.bpobgyn.2015.11.018. Epub 2015 Dec 2. Review.

PMID:
26725703
4.

PI3K-Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: an update.

Makker A, Goel MM, Das V, Agarwal A.

Gynecol Endocrinol. 2012 Mar;28(3):175-81. doi: 10.3109/09513590.2011.583955. Epub 2011 Sep 15. Review.

PMID:
21916800
5.

The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development.

Yang Q, Mas A, Diamond MP, Al-Hendy A.

Reprod Sci. 2016 Feb;23(2):163-75. doi: 10.1177/1933719115584449. Epub 2015 Apr 28. Review.

PMID:
25922306
6.

Dietary phytochemicals for possible preventive and therapeutic option of uterine fibroids: Signaling pathways as target.

Islam MS, Segars JH, Castellucci M, Ciarmela P.

Pharmacol Rep. 2017 Feb;69(1):57-70. doi: 10.1016/j.pharep.2016.10.013. Epub 2016 Oct 20. Review.

PMID:
27898339
7.

MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?

Karmon AE, Cardozo ER, Rueda BR, Styer AK.

Hum Reprod Update. 2014 Sep-Oct;20(5):670-87. doi: 10.1093/humupd/dmu017. Epub 2014 Apr 4. Review.

PMID:
24706045
8.

Recent Advances in Uterine Fibroid Etiology.

McWilliams MM, Chennathukuzhi VM.

Semin Reprod Med. 2017 Mar;35(2):181-189. doi: 10.1055/s-0037-1599090. Epub 2017 Mar 9. Review.

9.

[Molecular and cytogenetic evidence for the development of fibroids].

Knapp P, Chabowski A.

Postepy Hig Med Dosw (Online). 2012 Jan 30;66:23-32. Review. Polish.

10.

Receptor tyrosine kinases and their hormonal regulation in uterine leiomyoma.

Yu L, Moore AB, Dixon D.

Semin Reprod Med. 2010 May;28(3):250-9. doi: 10.1055/s-0030-1251482. Epub 2010 Apr 22. Review.

11.

The Eker rat: establishing a genetic paradigm linking renal cell carcinoma and uterine leiomyoma.

Cook JD, Walker CL.

Curr Mol Med. 2004 Dec;4(8):813-24. Review.

PMID:
15579028
12.

Role of vitamin D in uterine fibroid biology.

Brakta S, Diamond JS, Al-Hendy A, Diamond MP, Halder SK.

Fertil Steril. 2015 Sep;104(3):698-706. doi: 10.1016/j.fertnstert.2015.05.031. Epub 2015 Jun 13. Review.

13.

Endocrine-disrupting chemicals and uterine fibroids.

Katz TA, Yang Q, TreviƱo LS, Walker CL, Al-Hendy A.

Fertil Steril. 2016 Sep 15;106(4):967-77. doi: 10.1016/j.fertnstert.2016.08.023. Epub 2016 Aug 21. Review.

14.

Fibroids: Genotype and Phenotype.

Ordulu Z.

Clin Obstet Gynecol. 2016 Mar;59(1):25-9. doi: 10.1097/GRF.0000000000000177. Review.

15.

A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays.

Leppert PC, Catherino WH, Segars JH.

Am J Obstet Gynecol. 2006 Aug;195(2):415-20. Epub 2006 Apr 25. Review.

16.

Use of dietary phytochemicals to target inflammation, fibrosis, proliferation, and angiogenesis in uterine tissues: promising options for prevention and treatment of uterine fibroids?

Islam MS, Akhtar MM, Ciavattini A, Giannubilo SR, Protic O, Janjusevic M, Procopio AD, Segars JH, Castellucci M, Ciarmela P.

Mol Nutr Food Res. 2014 Aug;58(8):1667-84. doi: 10.1002/mnfr.201400134. Epub 2014 Jun 30. Review.

17.

Mouse models of uterine corpus tumors: clinical significance and utility.

Friel AM, Growdon WB, McCann CK, Olawaiye AB, Munro EG, Schorge JO, Castrillon DH, Broaddus RR, Rueda BR.

Front Biosci (Elite Ed). 2010 Jun 1;2:882-905. Review.

PMID:
20515761
18.

Recent scientific advances in leiomyoma (uterine fibroids) research facilitates better understanding and management.

Taylor DK, Holthouser K, Segars JH, Leppert PC.

F1000Res. 2015 Jul 6;4(F1000 Faculty Rev):183. doi: 10.12688/f1000research.6189.1. eCollection 2015. Review.

19.

Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction.

Ciavattini A, Di Giuseppe J, Stortoni P, Montik N, Giannubilo SR, Litta P, Islam MS, Tranquilli AL, Reis FM, Ciarmela P.

Obstet Gynecol Int. 2013;2013:173184. doi: 10.1155/2013/173184. Epub 2013 Sep 12. Review.

20.

Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy.

Borahay MA, Al-Hendy A, Kilic GS, Boehning D.

Mol Med. 2015 Apr 13;21:242-56. doi: 10.2119/molmed.2014.00053. Review.

Supplemental Content

Support Center